Used in pharmaceutical research as a key intermediate in the synthesis of tyrosine kinase inhibitors, particularly those targeting epidermal growth factor receptor (EGFR) pathways. It plays a role in the development of anticancer agents due to its ability to support the formation of compounds with high selectivity and potency against tumor cells. Its structure enables effective binding interactions in kinase domains, making it valuable in optimizing drug candidates for improved metabolic stability and bioavailability. Also employed in structure-activity relationship (SAR) studies to enhance antitumor activity and reduce off-target effects in new oncology therapeutics.